Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lineage Cell Therapeutics, Inc. LCTX

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for...


NYSEAM:LCTX - Post by User

User Avatar Image
(133)
•••
  • unclepiemanX
Post by unclepiemanon Jan 11, 2021 4:16pm
116 Views
Post# 32269409

starting to look really good!

starting to look really good!So we have a catalyst Q1/Q2 2021 on Dry AMD. A $10B market with no solution and LCTX might be the answer!


I'm Long in BTI.V, LCTX, GERN, SLS, ICO.v, MMIRF, TNDM and recently went Long on LPCN, DMAC, ETTX.


GLTA

<< Previous
Bullboard Posts